In-hospital mortality associated with the use of intra-aortic balloon counterpulsation

Philip M Urban; Robert J Freedman; E Magnus Ohman; Gregg W Stone; Jan T Christenson; Marc Cohen; Michael F Miller; Debra L Joseph; David Z Bynum; James J Ferguson 3rd; Benchmark Registry Investigators

doi:10.1016/j.amjcard.2004.03.058

In-hospital mortality associated with the use of intra-aortic balloon counterpulsation

Am J Cardiol. 2004 Jul 15;94(2):181-5. doi: 10.1016/j.amjcard.2004.03.058.

Authors

Philip M Urban¹, Robert J Freedman, E Magnus Ohman, Gregg W Stone, Jan T Christenson, Marc Cohen, Michael F Miller, Debra L Joseph, David Z Bynum, James J Ferguson 3rd; Benchmark Registry Investigators

Affiliation

¹ La Tour Hospital, Geneva, Switzerland. [email protected]

PMID: 15246896
DOI: 10.1016/j.amjcard.2004.03.058

Abstract

We analyzed in-hospital mortality for patients treated with intra-aortic balloon counterpulsation from the Benchmark Counterpulsation Outcomes Registry (n = 25,136). In-hospital mortality was higher in patients who received only medical interventions (32.5%) than in those who underwent percutaneous (18.8%) and surgical (19.2%) interventions, and was greatest in the first days after hospital admission for all 3 intervention types. Therefore, diagnostic evaluation and treatment decisions should be made as early as possible, and physicians should be aware of associated risk factors in making choices for patients.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Angioplasty, Balloon, Coronary
Coronary Disease / mortality*
Coronary Disease / surgery
Coronary Disease / therapy*
Female
Hospital Mortality*
Humans
Intra-Aortic Balloon Pumping* / mortality
Male
Middle Aged
Multicenter Studies as Topic
Outcome Assessment, Health Care
Registries
Risk Factors
Survival Analysis
Switzerland / epidemiology